Discovery of a multi-target compound for estrogen receptor-positive (ER+) breast cancer: Involvement of aromatase and ERs-Reference-Cited by-同舟云学术

Discovery of a multi-target compound for estrogen receptor-positive (ER+) breast cancer: Involvement of aromatase and ERs

Published:2021-02 Issue: Volume:181 Page:65-76
ISSN:0300-9084
Container-title:Biochimie
language:en
Short-container-title:Biochimie

Author:

Almeida Cristina Ferreira,Teixeira Natércia,Oliveira Ana,Augusto Tiago V.,Correia-da-Silva Georgina,Ramos Maria João,Fernandes Pedro Alexandrino,Amaral Cristina

Funder

Fundação para a Ciência e a Tecnologia

Publisher

Elsevier BV

Subject

General Medicine,Biochemistry

Reference83 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;Ca - Cancer J. Clin.,2018

2. Acquired resistance to aromatase inhibitors: where we stand!;Augusto;Endocr. Relat. Canc.,2018

3. Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells;Chan;J. Steroid Biochem. Mol. Biol.,2016

4. Molecular characterization of aromatase;Hong;Ann. N. Y. Acad. Sci.,2009

5. Novel aromatase inhibitors by structure-guided design;Ghosh;J. Med. Chem.,2012

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aromatase inhibitors for the treatment of breast cancer: An overview (2019–2023);Bioorganic Chemistry;2024-10

2. Sex-specific outcomes in cancer therapy: the central role of hormones;Frontiers in Medical Technology;2024-02-01

3. Design, synthesis and anticancer evaluation of polymethoxy aurones as potential cell cycle inhibitors;Heliyon;2023-10

4. A comparative study of Bazedoxifene, Exemestane, Fulvestrant, Raloxifene, Tryprostatin A, and Vorinostat compounds as potential inhibitors against breast cancer through molecular docking, and molecular dynamics simulation;Chinese Journal of Analytical Chemistry;2023-10

5. Deciphering the roles of aryl hydrocarbon receptor (AHR) in regulating carcinogenesis;Toxicology;2023-08